This paper is in the following e-collection/theme issue:

Extended Reality, Virtual Reality and Virtual Worlds (560) Registered Report (560) Digital Mental Health Interventions, e-Mental Health and Cyberpsychology (1514) Cost-Effectiveness and Economics (252) Virtual Reality Interventions in Mental Health (122) Psychotic Disorders (160) Reimbursement Strategies for XR and Spatial Computing (3)

Published on in Vol 24, No 11 (2022): November

This is a member publication of University of Oxford (Jisc)

Estimating the Economic Value of Automated Virtual Reality Cognitive Therapy for Treating Agoraphobic Avoidance in Patients With Psychosis: Findings From the gameChange Randomized Controlled Clinical Trial

Estimating the Economic Value of Automated Virtual Reality Cognitive Therapy for Treating Agoraphobic Avoidance in Patients With Psychosis: Findings From the gameChange Randomized Controlled Clinical Trial

Estimating the Economic Value of Automated Virtual Reality Cognitive Therapy for Treating Agoraphobic Avoidance in Patients With Psychosis: Findings From the gameChange Randomized Controlled Clinical Trial

Authors of this article:

James Altunkaya1 Author Orcid Image ;   Michael Craven2, 3, 4 Author Orcid Image ;   Sinéad Lambe5, 6 Author Orcid Image ;   Ariane Beckley5 Author Orcid Image ;   Laina Rosebrock5, 6 Author Orcid Image ;   Robert Dudley7 Author Orcid Image ;   Kate Chapman8 Author Orcid Image ;   Anthony Morrison9, 10 Author Orcid Image ;   Eileen O'Regan11 Author Orcid Image ;   Jenna Grabey12 Author Orcid Image ;   Aislinn Bergin2, 4, 13 Author Orcid Image ;   Thomas Kabir14 Author Orcid Image ;   Felicity Waite5, 6 Author Orcid Image ;   Daniel Freeman5, 6 Author Orcid Image ;   José Leal1 Author Orcid Image
Article Authors Cited by (9) Tweetations (39) Metrics

James Altunkaya   1 , MSc ;   Michael Craven   2, 3, 4 , PhD ;   Sinéad Lambe   5, 6 , DClinPsy ;   Ariane Beckley   5 , MSc ;   Laina Rosebrock   5, 6 , PhD ;   Robert Dudley   7 , PhD ;   Kate Chapman   8 , DClinPsy ;   Anthony Morrison   9, 10 , DClinPsy ;   Eileen O'Regan   11 , MB, MRCPsych ;   Jenna Grabey   12 , MSc ;   Aislinn Bergin   2, 4, 13 , PhD ;   Thomas Kabir   14 , PhD ;   Felicity Waite   5, 6 , DClinPsy ;   Daniel Freeman   5, 6 , PhD ;   José Leal   1 , DPhil

1 Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom

2 National Institute for Health and Care Research MindTech Med-Tech Co-operative, Nottingham, United Kingdom

3 Human Factors Research Group, Faculty of Engineering, University of Nottingham, Nottingham, United Kingdom

4 Mental Health & Technology Theme, National Institute for Health and Care Research Nottingham Biomedical Research Centre, Nottingham, United Kingdom

5 Department of Psychiatry, University of Oxford, Oxford, United Kingdom

6 Oxford Health NHS Foundation Trust, Oxford, United Kingdom

7 Cumbria, Northumberland, Tyne, and Wear NHS Foundation Trust, Newcastle upon Tyne, United Kingdom

8 Avon and Wiltshire Mental Health Partnership (AWP) NHS Trust, Bath, United Kingdom

9 Greater Manchester Mental Health Foundation Trust, Manchester, United Kingdom

10 Division of Psychology and Mental Health, University of Manchester, Manchester, United Kingdom

11 Nottinghamshire Healthcare NHS Foundation Trust, Nottingham, United Kingdom

12 Oxford Primary Care Clinical Trials Unit, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom

13 Mental Health & Clinical Neurosciences, School of Medicine, Institute of Mental Health, University of Nottingham, Nottingham, United Kingdom

14 McPin Foundation, London, United Kingdom

Corresponding Author:

  • José Leal, DPhil
  • Health Economics Research Centre
  • Nuffield Department of Population Health
  • University of Oxford
  • Richard Doll Building
  • Old Road Campus
  • Oxford, OX3 7LF
  • United Kingdom
  • Phone: 44 1865 289263
  • Email: jose.leal@dph.ox.ac.uk